Neuro-Oncology Volume 27 Issue 5 May 2025 by Oxford University Press
Neuro-Oncology Volume 27 Issue 5 May 2025 by Oxford University Press
Couldn't load pickup availability
Specialist research and clinical insights for neuroscience professionals
Very Good Condition – light edge wear visible.
A Phase 3 trial comparing radiation alone versus radiation with temozolomide for grade II gliomas provides new evidence for combination therapy approaches. The ECOG-ACRIN E3F05 study evaluated outcomes in 172 patients over a median follow-up period of 117 months, offering substantial data on survival benefits and toxicity profiles.
Shipping Information
Shipping Information
Orders dispatched within 24 hours. Standard delivery 3–5 business days. Express delivery available at checkout. View full shipping policy →
Returns & Warranty
Returns & Warranty
30-day returns accepted on all items in original condition. Change-of-mind returns welcome. Sale items excluded. View full returns policy →
FAQ & Support
FAQ & Support
Have a question? Browse our FAQ page or contact our team for help.
Customers are saying
- Choosing a selection results in a full page refresh.
- Opens in a new window.